You are here: Industry Insights > GlaxoSmithKline

News List

GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix fiercepharma
October 18, 2017
The Canadian approval covers people 50 years or older, as a prevention tool against the painful condition that's caused by latent varicella infection.
Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag fiercepharma
September 21, 2017
Big Pharma’s businesses in emerging markets grew 6.1% sequentially in the second quarter, the fastest in more than two years, according to a recent tally by Bernstein analysts, but some grew much faster than others.
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy fiercepharma
September 20, 2017
Bracing for generic competition to its top-selling Advair, GlaxoSmithKline nabbed an FDA approval for the "closed-triple" COPD therapy Trelegy Ellipta.
GSK, Innoviva announce US nod for Trelegy Ellipta pharmatimes
September 20, 2017
GlaxoSmithKline and Innoviva have bagged a green light in the US for the novel triple therapy inhaler Trelegy Ellipta, opening the door to a new treatment option for patients with Chronic Obstructive Pulmonary Disorder (COPD).
GlaxoSmithKline Japan selects SciBite Semantic platform to enhance pharmacovigilance capabilities pharmaasia
September 13, 2017
GSK Japan has selected SciBite's Semantic Platform to deliver on its commitment to improve the quality of human life.
Walter Reed, PATH to test modified regimen of GlaxoSmithKline’s Mosquirix fiercepharma
September 12, 2017
Just as GlaxoSmithKline's Mosquirix is set to undergo a pilot study among infants in three African countries, PATH and U.S. Army researchers are trying to determine if modifications to the regimen could provide better protection.
GlaxoSmithKline Japan Selects SciBite Semantic Platform to Enhance Pharmacovigilance americanpharmaceuticalreview.
September 01, 2017
GlaxoSmithKline has selected SciBite's Semantic Platform to enhance pharmacovigilance capabilities and deliver on its commitment to improve the quality of human life.
Vaccine market expected to grow at a CAGR of 7.5% by 2022 pharmaasia
August 29, 2017
The vaccine market is forecast to reach US$49.27 billion by 2022 at a CAGR of 7.5% from US$34.30 billion in 2017.
GlaxoSmithKline, Propeller widen respiratory sensor collaboration for COPD edge fiercepharma
August 25, 2017
Just weeks after appointing a new chief digital officer, Karenann Terrell, GlaxoSmithKline is pushing its digital efforts with an expanded Propeller Health collaboration.
GSK, Propeller expand digital health collaboration fiercebiotech
August 25, 2017
The Propeller sensor and GlaxoSmithKline's Ellipta inhaler (left) and the Propeller app.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page